Widex-Developed Artificial Intelligence Promises to Revolutionize Hearing Aids

Widex is the first hearing aid company to use AI to optimize hearing aid performance in real-time.

Widex notes having transformed the performance of a broad spectrum of consumer and industrial products, artificial intelligence (AI) is now set to revolutionize the quality of a product that the U.S. National Institutes of Health says half of the consumers aged 75 and over desperately need: hearing aids.

Bringing opportunity to fruition, Widex is the first hearing aid manufacturer to utilize real-time AI to create a better, more natural and personalized sound experience for hearing aid users. “By applying artificial intelligence, a hearing solution learns how users prefer various listening environments and gives them greater control over their hearing experience,” Widex Head of Audiology Lise Henningsen said. “By being the first to embrace AI, Widex benefits from years of continuous machine learning and hearing aid optimization that other hearing aid manufacturers have not yet developed. It is a key reason Widex is able to deliver its revolutionary natural sound.”

Powered by AI, Widex SoundSense Learn processes inputs from connected hearing aids throughout the world and shares anonymized data with a cloud-based AI system. The system then continuously learns how to further optimize hearing aid settings in different situations for specific wearers.

Widex SoundSense Learn presents users with A-B comparisons to begin understanding how a person wearing compatible Widex hearing aids prefers sound in an environment. SoundSense Learn manages three acoustic parameters — low, mid, and high frequencies — which can each be set to 13 different levels, resulting in more than 2,000 possible settings.

To A-B test each setting would require more than 2 million tests, but by using the power of machine-learning algorithms, Widex SoundSense Learn requires only about a dozen comparisons to calculate the optimal settings for the individual person. The SoundSense Learn algorithms also track the user’s individual adjustments and draw from other user settings stored in the cloud to more precisely tailor the hearing aids to one’s surroundings.

When applied, the settings create a personalized hearing experience based on context, content, and intent. Users can store the settings as programs in their smartphones and activate them throughout the day, such as when they’re at work, at the supermarket, or in their kitchen. Anonymized, the programs can also be stored in a secure, cloud-based system and help enhance the hearing experience of other users.

“Our studies show that hearing aid users have a significant preference for the personalized settings achieved through artificial intelligence and machine learning, and that 80 percent would recommend the function to others,” Henningsen added.

AI-equipped hearing aids such as the WIDEX MOMENT enhance our digital lives. “With AI, they are more like new lifestyle ‘hearables,’ which are key contributors to ubiquitous computing, just as virtual assistants and smart watches are,” Henningsen concluded.

SourceWidex

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version